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Recently, heater/humidifier devices that use novel methods to condition breathing gases from
an external source have been introduced. The addition of sufficient warmth and high levels of
humidification to breathing gas has allowed for higher flow rates from nasal cannula devices to
be applied to patients (i.e., high flow therapy). This article provides a review of the proposed
mechanisms behind the efficacy of high flow therapy via nasal cannula, which include washout
of nasopharyngeal dead space, attenuation of the inspiratory resistance associated with the
nasopharynx, improvement in conductance and pulmonary compliance, mild distending pres-
sure and reduction in energy expenditure for gas conditioning.
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Relative to progress and complexities of modern mechan-
ical ventilators, advancement in technology to efficiently
warm and humidify respiratory source gases has been
lagging. Recently, devices that use a variety of different
methods to condition breathing gases from an external
source, have been introduced for use in patients across all
ages and in clinical or home settings. Heretofore, insuffi-
cient humidification has limited use of high supplemental
gas flow rates delivered through the nose. The addition of
sufficient warmth and high levels of humidification to the
breathing gas has allowed for higher flow rates from nasal
cannula (NC) devices to be applied to patients. Patients
ranging in ages from preterm newborns to adults are now
receiving flow rates ranging from 2 to 40 L/min to support
breathing through a variety of conditions. In newborns, high
flow devices are being used in the preterm population with
respiratory distress syndrome as well as a mode for oxygen
delivery in full term newborns with hypoxic respiratory
failure. In the pediatric age range, high flow devices are
finding use in typical situations that might have otherwise
required intubation or CPAP. Disease processes from
infectious causes of pulmonary dysfunction such as viral
bronchiolitis or bacterial pneumonia to reactive airway
disease are being treated now high flow cannula devices. In
adults, these devices are used in a variety of clinical
settings where increased flow rates are believed to benefit
the patient in the context of their respiratory disease.
These adult disease processes range from pulmonary edema
to chronic obstructive pulmonary disease (COPD) to acute
respiratory distress syndrome (ARDS) post-extubation. This
article provides a review of the proposed mechanisms
behind such devices.
Mechanisms of action for high flow
therapy (HFT)
The use of high flow therapy (HFT) devices in clinical settings
is rapidly growing. These devices are being applied to
patients across age groups in a variety of disease conditions.
The mechanisms through which HFT devices affect the
respiratory system and alter gas exchange are still under
investigation but a growing body of evidence is supporting
the mechanisms of action for HFT to be five-fold.
1) HFT provides for washout of nasopharyngeal dead
space, which contributes to establishing improved
fraction of alveolar gases with respect to carbon
dioxide as well as oxygen.1
2) The distensibility of the nasopharynx provides signifi-
cant resistance on inspiratory relative to expiratoryefforts.2 HFT provides adequate flow rates to match
inspiratory flow and thus markedly attenuates the
inspiratory resistance associated with the nasopharynx,
and thus eliminates related work of breathing.
3) The provision of adequately warmed and humidified gas
to the conducting airways improves conductance and
pulmonary compliance compared to dry, cooler gas.3
4) The provision of adequately warmed and humidified gas
through the nasal pharynx reduces the metabolic work
associated with gas conditioning.
5) High flow through the nasopharynx can be titrated to
provide positive distending pressure for lung
recruitment.4
Washout of nasopharyngeal dead space
A principle mechanism of action for HFT may be through
flushing the dead space of the nasopharyngeal cavity,
thereby reducing overall dead space and resulting in
alveolar ventilation as a greater fraction of minute venti-
lation. Thus, there is an improvement in the efficiency of
respiratory efforts. The essential clinical criteria to remain
on non-invasive respiratory support modes are effective
spontaneous respiratory effort and CO2 elimination.
Hypercapnia, or apnea that may be secondary to hyper-
capnia, are the most common reasons for progressing to
more invasive forms of ventilatory support. Therefore, if
CO2 retention during conventional non-invasive ventilation
(such as continuous positive airway pressure [CPAP]) can
be reduced or eliminated, many patients can be spared
invasive mechanical ventilation and the associated
potential lung injury and subsequent chronic lung and
airway diseases.
A reasonable comparison for this dead space washout
mechanism is to tracheal gas insufflation (TGI). Dead space
washout by way of TGI has been demonstrated with
numerous studies to enhance minute ventilation by
promoting CO2 elimination.
5e9 By reducing prosthetic dead
space, TGI facilitates pulmonary gas exchange and reduces
the ventilator pressure and volume requirements.10,11
Studies in juvenile animal models of acute lung injury have
demonstrated that TGI using a novel endotracheal tube
design reduces physiological dead space during mechanical
ventilation. Both pressure and volume requirements to
support gas exchange were lower than with conventional
mechanical ventilation (CMV). Importantly, corresponding
biomarkers of lung structure were improved and those of
lung and systemic inflammation were attenuated as
compared to CMV with lower peak inspiratory pres-
sures.12,13 These studies support that dead space washout
offers potential as a lung protective strategy for acute
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adjunct to respiratory management.
Subsequent to the mechanical ventilation studies, Nakos
and colleagues investigated the use of TGI in spontaneously
breathing patients and demonstrated reductions in PaCO2,
tidal volume, minute ventilation and dead space.14 These
results were demonstrated in adults with COPD that were
weaned from mechanical ventilation. This approach has
also been evaluated in early development. In this regard,
TGI was used with CPAP in intubated animals using
a specially designed endotracheal tube to allow for insuf-
flation gas flow (No. 6501.30; Vygon, Ecouen, France).15
The results were robust with respect to the reduction in
CO2 retention by spontaneously breathing piglets with oleic
acid induced mild respiratory distress. However, the impact
of this study was limited because the piglets needed to be
intubated to accomplish TGI with the Vygon endotracheal
tube. Application of such a therapy would, in theory,
dramatically increase the number of infants that can be
sustained without mechanical ventilation, or weaned
sooner.
Data from published clinical studies support the theory
that HFT eliminates dead space because of the immediate
impact on ventilation rates. A study by Dewan and Bell
investigated exercise tolerance in COPD patients receiving
respiratory support by transtracheal catheters (TTC), and
compared low and high flows through nasal cannulae to low
and high flow through the TTCs.1 TTCs are catheters placed
in the patient’s trachea for the direct purpose of increasing
respiratory efficiency by TGI dead space washout. Dewan
and Bell showed that exercise tolerance was greater for
high flow than low flow regardless of method of adminis-
tration (p< 0.01), but high flow via nasal cannula was just
as effective for dead space washout as with TTC. These
data confirm that dead space washout is a primary mech-
anism of action during HFT.
A neonatal trial of an early extubation protocol done
Holleman-Duray et al. showed that infants extubated to
HFT, compared to other non-invasive support modes, from
significantly greater ventilator rates (33 8 vs
28 8 breaths/min; p< 0.05).16 In another example,
a published case report on a pediatric burn patient showed
that respiratory rate decreased immediately following
initiation of Vapotherm HFT (63e38 breaths/min), with
a secondary sustained decrease in heart rate (175e
144 beats/min) after a short period.17
Dead space removal also has an impact on oxygenation.
Data from Chatila and colleagues demonstrated in exer-
cising adult chronic obstructive pulmonary disease (COPD)
patients that HFT compared to conventional low flow
through nasal prongs enhanced oxygenation.18 During
matched workloads and with matched inspiratory oxygen
fraction, exercising patients maintained greater arterial
oxygen tension (p< 0.001) despite a reduction in respira-
tory rate (p< 0.05) while using HFNC. While using HFT
these patients were able to exercise longer (10 2 vs
8 4 min; p< 0.05), and these patients also maintained
arterial CO2 and pH while breathing less frequently with no
change in tidal volumes.
A few studies published as abstracts reinforce the
nasopharyngeal washout effect by evaluating oxygen
concentration of the airways and lungs. The use of a benchmodel showed that airway oxygen fractions were greater
with the use of HFT via nasal cannula versus non-
rebreathing masks.19,20 Additionally, a study in normal
human subjects showed that nasopharyngeal oxygen
concentrations were greater with higher flow rates, and
greater if the patients has an open mouth.21
Reduction of inspiratory resistance (work of
breathing) by providing adequate flow
The design of the nasopharynx facilitates humidification
and warming of inspired gas by contact with the large
surface area. By definition, this large wet surface area and
nasopharyngeal gas volume can account for an appreciable
resistance to gas flow. In addition, after analyzing nasal and
oral flow-volume loops, Shepard and Burger showed that
the nasopharynx has a distensibility that contributes to
variable resistance.2 When inspiratory gas is drawn across
this large surface area, retraction of the nasopharyngeal
boundaries results in a significant increase in inspiratory
resistance compared to expiratory resistance. CPAP has
been shown to reduce this supraglottic resistance up to 60%
by mechanically splinting the airways.22 However, HFT most
likely minimizes the inspiratory resistance associated with
the nasopharynx by providing nasopharyngeal gas flows that
match or exceed a patient’s peak inspiratory flow. This
change in resistance translates to a decrease in resistive
work of breathing.
Saslow and colleagues published data from neonates
indicating that work of breathing with HFT between 3 and
5 L/min was equivalent to that with nasal CPAP set to
6 cm H2O.
23 This reported equivalency was shown despite
a significantly lower esophageal pressure (1.32 0.77 vs
1.76 1.46 cmH2O; p< 0.05); thus, there is a mechanism
of action other than distending pressure effecting work of
breathing with HFT.
The effects of high nasal gas flows on expiration are less
understood; however, comparison to other devices supports
some hypotheses on what happens during the expiratory
phase. The Infant Flow CPAP driver incorporates the
Coanda effect in switching flow during expiration, such that
the patient experiences an entrainment effect of expira-
tory gas during expiration.24,25 In this regard, one might
speculate that during HFT, inspiratory flow is split such that
a portion of gas flow enters the trachea and a smaller
portion exits the mouth. During expiration, it is possible
that the exiting gas from the trachea separates gas flow
from the back wall of the nasopharynx by disrupting the
boundary layer, thus assisting expiration out the mouth
similar to the infant flow device. Thus, the Coanda effect
would be experienced by the patient in the nasopharyngeal
region during expiration and potentially assisting expiratory
efforts.
Improved mechanics by supplying adequately
warmed and humidified gas
Studies from the 1990’s demonstrated the negative effects
of using non-warmed, non-humidified gas to support respi-
ration. Dr. Greenspan and colleagues demonstrated that
just five minutes of respiration with ambient gas, not
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a significant decrease in both pulmonary compliance and
conductance.3 Furthermore, Fontanari and colleagues
showed that receptors in the nasal mucosa respond to cold
and dry gas to elicit a protective bronchoconstrictor
response in both normal subjects26 and asthmatics.27 On
and colleagues showed this cool, dry air induced broncho-
constriction response to be associated with muscarinic
receptors in the nasal mucosa.28
In non-intubated infants receiving respiratory support by
nasal cannula, Saslow and colleagues showed greater
respiratory compliance in infants with 5 L/min of HFT
conditioned gas compared to 6 cm H2O of conventional
CPAP using a standard humidification unit (1.03 0.47 vs
0.83 0.49 ml/cm H2O/kg).23 These compliance data were
despite a significantly lower esophageal pressure in the HFT
treated infants (1.32 0.77 vs 1.76 1.46 cmH2O;
p< 0.05). Because HFT resulted in less distending pressure,
and therefore less functional residual volume, these data
support the proposition that adequacy of conditioning for
breathing gas does impact the physiologic response of the
organ tissues. These study findings agree with those of Dr.
Greenspan and colleagues with respect to compliance;
however, regarding airway conductance, this parameter
was not measured in the Saslow study.
Reduction in the metabolic cost of gas conditioning
Under normal physiologic functioning of the respiratory
tract, the nasal air passages warm inspiratory air from
ambient to 37 C and humidify the incoming air to 100%
relative humidity (RH).29e31 Whereas many of the factors
involved in this process are unclear or not easily definable,
we believe that it can be ascertained that there is some
significant energy cost to the process of gas conditioning.
By definition, gas that is at 100% RH holds as much water
as possible before water droplets begin to spontaneously
form. Furthermore, Dalton’s law dictates that as gas gets
warmer it hold more water vapor per unit volume at any
percent RH. Thus, as gas is conditioned by the nasal
mucosa, heat energy is required not only to warm the air,
but also vaporize water into the air. This process of water
vaporization requires a significant amount of heat energy in
the same way that sweating cools our bodies on a warm
day.32 However, the times when gas conditioning presents
the greatest thermal challenge are when the ambient air is
cooler and drier, thus body heat is typically not in reserve.
In this regard, the nasal mucosal tissues likely need to
produce this heat for warming and water vaporization.
The most simplistic formula for the energy requirement
of gas conditioning is represented as:
Etotal=LZEg$ð37 TambÞ þ Evap$ð44 mg AHambÞ
Here, Etotal/L is the total energy required per liter of
inspired gas, Eg is the energy required to raise 1 L of gas
1 C (roughly 1.2 J), and Evap is the energy required to raise
1 mg of water from 37 to 100 C plus the latent heat of
vaporization for 1 mg of water (.263þ 2.260 J, respec-
tively). Tamb represents the ambient gas temperature,
which is subtracted from body temperature (37 C). AHamb
represents the absolute humidity of ambient gas per liter,and that is subtracted from the absolute humidity of gas at
body temperature and saturated (44 mg H2O/L).
As a typical example, consider inspiring ambient air that
is room temperature (21 C) and 50% RH (containing
9 mgwater/L). Each liter of air will need to be raised 16 C
and have 35 mg of water vaporized into it, requiring 107.5 J
(26 Calories) per liter of inspired gas. Therefore, an adult
with a typical 500 ml tidal volume and a respiratory rate of
12 breaths/min may require approximately 156 calories/
min for conditioning gas. Also, note that there must be some
metabolic cost of generating mucus and moving the water.
It is assumed that the nasal airways are very efficient at
capturing heat and moisture from expired gas to be recy-
cled on subsequent inspirations.29e31 Nonetheless, without
100% efficiency there is presumable some energetic cost to
conditioning inspired air. Furthermore, with lung patholo-
gies there is a rise in minute ventilation resulting in greater
gas volumes to be conditioned, and current non-invasive
therapies can supply gas flows to the nasal passages that
supersede minute volumes inspired to the lungs. In this
regard, utilizing HFT with a device that completely warms
and humidifies inspiratory gas likely impacts oxygen need
and CO2 production by reducing this energy requirement.
This presumption is supported by the clinical data indi-
cating improved weight gain in infants on Vapotherm
compared to those on conventional CPAP support.16
Provision of distending pressure
The form of non-invasive respiratory support most common
in the neonatal intensive care setting is continuous positive
airway pressure (CPAP).33 It is believed that providing dis-
tending pressure to the lungs results in improved ventila-
tory mechanics by optimizing lung compliance and assists
with gas exchange by maintaining patency of alveoli.34e36
Whereas HFT is not necessarily intended to provide CPAP, if
gas flow and nasal prong dimensions are set appropriately
for patient size distending pressure can be accomplished.
Nasal cannula size is a critical factor in determining CPAP
generation as it relates to air leak around the cannula prongs.
Dr. Locke and colleagues showed that using 2.0 cm OD nasal
prongs with conventional oxygen therapy (>2 L/min) does
not generate significant esophageal pressures or impact
breathing patterns; however, using a larger 3.0 cm OD
cannulae in the same infants produceda correlationbetween
gas flow and esophageal pressure (rZ 0.92), reaching
a mean pressure of 9.8 cmH2O at 2.0 L/min of flow.
37
Therefore, distending pressure provided by nasal cannula
and respiratory gas flow is dependent on leak rate, deter-
mined by the nasopharyngeal anatomy as well as the rela-
tionship between nasal prong size and nares of the nose. In
fact, a recent bench study by Kahn and colleagues showed
that even bubble CPAP results in appreciable overshoots of
pharyngeal pressurewhen the nasal prong size relative to the
nares allows for too little leak, and toomuch leak essentially
negates generation of intended pharyngeal pressure.38
Typically, CPAP generated by nasal cannula in the NICU
setting is done with approximately 1e3 L/min of flow with
adequate nasal prong size (relative to the nare internal
dimensions) and a closed mouth to create up to 8 cm H2O of
pharyngeal pressure.39 When flow and resistance compo-
nents are managed accordingly, bench data presented by
1404 K. Dysart et al.Limauro and colleagues indicated that HFT nasal cannulae
do not likely deliver a clinically relevant level of CPAP
unless an infant’s mouth is closed and the leak around the
nares minimized.40 In a follow-up clinical study, these
authors showed that oral pressures in 16 infants receiving
HFT were only clinically significant in the smallest infants
and when the mouth was closed.41 Spence and colleagues
demonstrated that HFT can be used effectively to provide
CPAP (<5 cmH2O in this study).
4 However, these researches
held the mouth closed with a strap on these infants and did
not report the nasal cannulae or nostril nare dimensions.
Wilkinson and colleagues recently showed that HFT in
infants can result in clinically relevant increases in
pharyngeal pressures, and that the pharyngeal pressure is
directly related to flow, but inversely related to infant
size.42 This study provides evidence to support the funda-
mental relationship between pressure and flow where
pressure is directly proportional to flow and resistance
(Pw F R). Therefore, as the infants get smaller in size,
the pressure resulting from any flow rate increased as
a result of the resistance provided by the smaller anatomy.
In this regard, major limitations of the study were that
nasal prong size (effecting leak around the prongs) was not
decreased with decreasing infant size to normalize the
resistance, and flow rates were not optimized. With respect
to the later point, it is likely that the smaller infants did not
require as much flow as the larger infants to effect dead
space washout and support inspiratory efforts.
Summary
HFT through nasal cannula is now a viable option because of
devices that completely warm and humidify inspiratory
gases to body temperature and 100% saturation. Properly
conditioned gas provides for patient comfort and minimizes
deterioration of nasopharyngeal structures. The mecha-
nisms of actions of HFT are five-fold: HFT 1) flushes dead
space of the nasopharyngeal cavity allowing for better
ventilation as well as oxygenation, 2) provides a flow
adequate to support inspiration therefore reducing inspira-
tory work of breathing, 3) improves lung and airway
mechanics by eliminating the effects of drying/cooling, 4)
reduces or eliminates themetabolic cost of gas conditioning,
and 5) can be used to provide end distending pressure.
Numerous studies have shown the safety and efficacy of
nasal cannula HFT in the acute care setting, and a number of
studies have demonstrated potential for HFT in terms of
efficacy beyond conventional oxygenation support.
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